JKJin Young Kang

Jin Young Kang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Jin Young Kang has a total of 117 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Noncanonical Reducing-Domain Architecture Defines a New Class of Modular Polyketide Synthases

    by Jin Young Kang, Jinwoo Kim, Byeongsub Lee, Jongseok Park, Hyeongwoo Kim, Minjae Kim, Gyu Sung Lee, Chung Sub Kim, Hyun Uk Kim

    Colibactin is a microbiome-derived genotoxin that damages the genomes of intestinal epithelial cells and has been linked to colorectal cancer. Its biosynthesis is encoded by a large gene cluster ( pks / clb ) that functions as a hybrid nonribosomal peptide synthetase - polyketide synthase assembly line, yet the structural basis of its assembly remains poorly understood. Here we show cryo-electron microscopy structures of colibactin biosynthetic enzyme ClbB that uncover a noncanonical architecture for a fully-reducing polyketide synthase module. Unlike metazoan fatty acid synthases and iterative polyketide synthases, ClbB arranges its condensing and reducing regions in a crossed configuration. Within its reducing region, the enoylreductase forms an inverted dimer and the dehydratase is positioned peripherally as monomers. Moreover, the dehydratase-enoylreductase unit is embedded within the ketoreductase fold. Bioinformatic analyses combined with deep-learning-based structure prediction indicate that this domain-embedding logic is broadly distributed across diverse bacterial phyla. These findings define a previously unrecognized class of reducing polyketide synthase modules and provide an expanded structural framework for understanding how modular polyketide synthases coordinate multi-step chemistry. The work also extends design principles for engineering megasynthases for chemical biosynthesis and synthetic biology.

  • Open Access

    A 3′ terminal sugar-specific polymerase for terminator-free single-nucleotide extension of RNA oligonucleotides

    by Joonyoung Lee, Seong-Gyu Lee, Jin Young Kang, Ki Jun Jeong

    Extant single-nucleotide extension (SNE) methods for oligonucleotide synthesis rely on terminator-modified substrates, which require complex nucleotide synthesis and induce side reactions that compromise fidelity. Here, we present deoxy-mononucleotide inhibited ligation (dMIL), a fully enzymatic, terminator-free SNE strategy. dMIL leverages a previously unrecognized primer 3′ terminal sugar specificity in E. coli poly(A) polymerase (EcPAP), where a single terminal deoxynucleotide completely blocks further extension. Cryo-EM structures of EcPAP across multiple catalytic states reveal a substrate-induced conformational switch in the N-terminal head domain mediating this sugar selectivity, the first such transition described in a class II nucleotidyltransferase. To exploit this mechanism, we engineered the strictly rATP-specific nucleotide binding pocket of EcPAP to accept all four canonical dNTPs while maintaining primer sugar discrimination, enabling quantitative, terminator-free SNE of RNA oligonucleotides. These findings establish EcPAP as a contender in enzymatic oligonucleotide synthesis and demonstrate, for the first time, a fully enzymatic route to SNE.

  • Open Access

    Cryo-EM structure of the LARS1:IARS1 complex reveals a nutrient-responsive switch controlling mTORC1 signaling

    by Youjin Kim, Joo-Chan Kim, Do-Wook Kim, Jinwoo Kim, Jaehun Choi, Seo Young Park, Jimin Lee, Ina Yoon, Sunghoon Kim, Jin Young Kang, et al.

    Aminoacyl-tRNA synthetases (ARSs) assemble into the multi-tRNA synthetase complex (MSC) to mediate noncanonical functions in cell signaling and stress responses. Among them, human cytosolic leucyl-tRNA synthetase 1 (LARS1) plays a central role in sensing leucine and activating mTORC1, thereby linking nutrient availability to metabolic regulation. Despite recent progress, fundamental questions remain unresolved about the regulatory mechanisms governing LARS1's non-canonical functions, particularly its structural organization within the MSC. Here, we employ an integrated approach combining structural, biochemical, and cellular analyses to investigate the noncanonical roles of LARS1. The cryo-EM structure of the LARS1:isoleucyl-tRNA synthetase 1 (IARS1) complex reveals that LARS1 binds to IARS1, its anchoring partner in the MSC, via its UNE-L domain. Amino acid stimulation induces LARS1 phosphorylation at Ser1070, Ser1077, and Ser1082, which are located at the interface with IARS1. These modifications disrupt the interaction, promote LARS1 dissociation from the MSC, and enable mTORC1 activation. This study highlights phosphorylation as a conserved and critical molecular switch that orchestrates the non-canonical functions of MSC by dynamically modulating the assembly and activity of its components in response to external stimuli.


  • Open Access

    Structural insights into modular polyketide synthases: From individual domains to supramolecular assemblies

    by Minjae Kim, Hyeongwoo Kim, Jin Young Kang

    Polyketide synthases (PKSs) are large, highly orchestrated enzymatic assemblies that produce a wide array of biologically active compounds with antibiotic, anticancer, and immunosuppressive properties. In particular, modular PKSs (mPKSs) are composed of multiple catalytic domains arranged in an assembly‐line fashion, typically encoded within gene clusters dedicated to polyketide biosynthesis. Recent advances in cryo‐electron microscopy have enabled high‐resolution structural characterization of diverse mPKSs, providing crucial insights into their molecular mechanisms and supporting structure‐guided engineering efforts. In this review, we introduce the individual domain structures and the overall domain architectures of mPKSs as revealed by recent structural studies. Despite the high conservation of individual domains, comparative analyses uncover unexpected variability in the overall architecture of PKS megasynthases, offering explanations for the limitations of earlier engineering attempts and suggesting strategies for more effective metabolic reprogramming.


  • Open Access

    Cryo-EM Structure of the LARS1-IARS1 Complex Reveals A Nutrient-Responsive Switch Controlling mTORC1 Signaling

    by Hee-Sung Park, Youjin Kim, Joo-Chan Kim, Do-Wook Kim, Jinwoo Kim, Jimin Lee, Sunghoon Kim, Jin Young Kang

    Aminoacyl-tRNA synthetases (ARSs) assemble into the multi-tRNA synthetase complex (MSC) to mediate noncanonical functions in cell signaling and stress responses. Among them, leucyl-tRNA synthetase 1 (LARS1) plays a central role in sensing leucine and activating mTORC1, thereby linking nutrient availability to metabolic regulation. Despite recent progress, fundamental questions remain unresolved about the regulatory mechanisms governing LARS1’s non-canonical functions, particularly its structural organization within the MSC. Here, we employed an integrated approach combining structural, biochemical, and cellular analyses to investigate the noncanonical roles of LARS1. The cryo-EM structure of the LARS1:Isoleucyl-tRNA synthetase 1 (IARS1) complex revealed that LARS1 binds to IARS1, its anchoring partner in the MSC, via its UNE-L domain. Amino acid stimulation induces LARS1 phosphorylation at Ser1070, Ser1077, and Ser1082, which are located at the interface with IARS1. These modifications disrupt the interaction, promote LARS1 dissociation from the MSC, and enable mTORC1 activation. This study highlights phosphorylation as a conserved and critical molecular switch that orchestrates the non-canonical functions of MSC by dynamically modulating the assembly and activity of its components in response to external stimuli.

  • Open Access

    Targeting CD155 in lung adenocarcinoma: A5 nanobody-based therapeutics for precision treatment and enhanced drug delivery

    by Kyunghee Noh, Soyeon Yi, Hyeran Kim, Jieun Lee, Suhyeon Kim, Wonbeak Yoo, Eunkyeong Jung, Jinsol Choi, Hwangseo Park, Seungha Hwang, et al.

    This study presents a novel approach targeting CD155, an overexpressed protein in lung adenocarcinoma (LUAD), using nanobodies with exceptional precision and efficacy. The significant upregulation of CD155 in LUAD, associated with poor patient outcomes, highlights its potential as a therapeutic target. An anti-CD155 nanobody (A5 Nb) is developed that binds to CD155-positive lung cancer cells with high affinity (A5 Nb K d = 0.23 nM). The complementarity-determining region of A5 Nb forms hydrophobic interactions and hydrogen bonds with CD155, promoting selective binding and stabilization of A5 Nb-CD155 complex. This interaction inhibits focal adhesion signaling by downregulating paxillin (PXN), leading to a >50% reduction in cell migration. Additionally, A5 Nb conjugated to liposomes loaded with doxorubicin (A5-LNP-DOX) demonstrates a 2- to 3-fold increase in uptake and cytotoxicity in CD155-positive A549 cells, suggesting its potential as a targeted drug delivery system. Therapeutic efficacy was further validated in both lung orthotopic mouse models and lung cancer organoid xenografts, where A5-LNP-DOX exhibited robust antitumor effects and selective targeting. The CD155-PXN axis emerges as a clinically relevant target, correlating with poor outcomes in patients with lung cancer. This study highlights the therapeutic potential of A5 nanobodies in targeting CD155-overexpressing lung cancer cells and offers insights for future developments in lung cancer therapeutics.


  • Structural study on human microbiome-derived polyketide synthases that assemble genotoxic colibactin

    by Minjae Kim, Jinwoo Kim, Gyu Sung Lee, Paul Dominic B. Olinares, Yougant Airan, Jasmine L. Chow, Jongseok Park, Yujin Jeong, Jiho Park, Brian T. Chait, et al.


  • Open Access

    Size-controlled assembly of phase separated protein condensates with interfacial protein cages

    by Hyeok Jin Oh, Yongsuk Lee, Haerang Hwang, Kibeom Hong, Hyeongjoo Choi, Jin Young Kang, Yongwon Jung

    Phase separation of specific proteins into liquid-like condensates is a key mechanism for forming membrane-less organelles, which organize diverse cellular processes in space and time. These protein condensates hold immense potential as biomaterials capable of containing specific sets of biomolecules with high densities and dynamic liquid properties. Despite their appeal, methods to manipulate protein condensate materials remain largely unexplored. Here, we present a one-pot assembly method to assemble coalescence-resistant protein condensates, ranging from a few μm to 100 nm in sizes, with surface-stabilizing protein cages. We discover that large protein cages (~30 nm), finely tuned to interact with condensates, efficiently localize on condensate surfaces and prevent the merging (coalescence) of condensates during phase separation. We precisely control condensate diameters by modulating condensate/cage ratios. In addition, the 3D structures of intact protein condensates with interfacial cages are visualized with cryo-electron tomography (ET). This work offers a versatile platform for designing size-controlled, surface-engineered protein condensate materials.


  • Practices in cryo-EM single particle analysis data processing: data transfer between RELION and cryoSPARC

    by Jinwoo Kim, Jin Young Kang

    Jinwoo Kim and Jin Young Kang. BioDesign 2024;12:29-38. https://doi.org/10.34184/kssb.2024.12.2.29


  • Open Access

    Size-controlled synthesis of phase separated protein condensates with interfacial protein cages

    by Hyeok Jin Oh, Yongsuk Lee, Haerang Hwang, Kibeom Hong, Hyeongjoo Choi, Jin Young Kang, Yongwon Jung

    Phase separation of specific proteins into liquidic condensates is a key mechanism to form membrane-less organelles, which organize diverse cellular processes in space and time. These protein condensates hold immense potential as biomaterials that can contain specific sets of biomolecules with extremely high densities and dynamic liquid properties. Despite their appeal, methods to manipulate protein condensate materials remain largely unexplored. Here, we developed a one-pot assembly method to synthesize coalescence-free protein condensates from a few μm to 100 nm sizes with surface-stabilizing protein cages. We discovered that large protein cages (~30 nm), with precisely tuned interaction strengths to condensates, could effectively localize on condensate surfaces and block coalescence during phase separation. This approach proved applicable to diverse condensates with varying compositions and fluidities. Condensate sizes were concisely controlled by modulating condensate/cage ratios. In addition, we successfully visualized the 3D structures of intact protein condensates with interfacial cages with cryo-electron tomography (ET). Protein cages formed monolayer shells on protein condensates, where cages were slightly buried in condensates with contact angles lower than 90 degree. These cage-covered protein condensates maintained dynamic properties, including the capacity for selective material exchange or recruitment from the external environment.